Kirsten Canté-Barrett

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

Sofie Peirs, Filip Matthijssens, Steven Goossens et al. · Blood · 2014 · 272 citations

Medicine, Hematology, Oncology +8

T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies

Valentina Cordo’, Jordy C.G. van der Zwet, Kirsten Canté-Barrett et al. · Blood Cancer Discovery · 2020 · 144 citations · Full text

Medicine, Molecular Genetics, Oncology +17

IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study

Yunlei Li, Jessica G. C. A. M. Buijs-Gladdines, Kirsten Canté-Barrett et al. · PLoS Medicine · 2016 · 104 citations · Full text

Medicine, Molecular Genetics, Oncology +17

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia

Kirsten Canté-Barrett, J A P Spijkers-Hagelstein, Jessica G. C. A. M. Buijs-Gladdines et al. · Leukemia · 2016 · 91 citations · Full text

Medicine, Cancer Biology, Oncology +15

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling

Steven Goossens, Enrico Radaelli, Odile Blanchet et al. · Nature Communications · 2015 · 88 citations · Full text

Medicine, Molecular Genetics, Oncology +17